MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
A biotechnology company called MetaVia Inc., which focuses on transforming cardiometabolic diseases, revealed that its President and CEO, Hyung Heon Kim, is set to take part in a fireside chat. The company made this announcement today in Cambridge, Mass., dated June 17, 2026. MetaVia Inc. is listed on Nasdaq with the ticker symbol MTVA.
